The little women of loja — growth hormone–receptor deficiency in an inbred population of southern ecuador

New England Journal of Medicine

Volumn 323, Issue 20, 1990, Pages 1367-1374

  Rosenbloom, Arlan L ^a   Aguirre, Jaime Guevara ^b   Rosenfeld, Ron G ^c   Fielder, Paul J ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b Inst Endocrinol   (Ecuador)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DWARFISM; ECUADOR; FEMALE; FETUS DEATH; GROWTH HORMONE DEFICIENCY; HEREDITY; HUMAN; MALE; PEDIGREE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CONSANGUINITY; DWARFISM; ECUADOR; FEMALE; GROWTH HORMONE; HUMAN; INFANT; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGE; RECEPTORS, SOMATOTROPIN; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025222960     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199011153232002     Document Type: Article

References (39)

1. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone — a new inborn error of metabolism? Isr J Med Sci 1966; 2: 152–5.
2. Laron Z, Pertzelan A, Karp M. Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 1968; 4: 883–94.
3. Laron Z, Karp M, Pertzelan A, Kauli R, Keret R, Doron M. The syndrome of familial dwarfism and high plasma immunoreactive human growth hormone (IR-hGH). In: Pecile A, Muller EE, eds. Growth and growth hormone. Amsterdam: Excerpta-Medica, 1972:458–82.
4. Laron Z, Sarel R, Pertzelan A. Puberty in Laron type dwarfism. Eur J Pediatr 1980; 134: 79–83.
5. Najjar SS, Khachadurian AK, Ilbawi MN, Blizzard RM. Dwarfism with elevated levels of plasma growth hormone. N Engl J Med 1971; 284: 809–12.
6. Clemons RD, Costin G, Kogut MD. Laron dwarfism: growth and immunoreactive insulin following treatment with human growth hormone. J Pediatr 1976; 88: 427–33.
7. McGraw ME, Price DA, Hill DJ. Somatomedin C deficiency in Asian sisters. Arch Dis Child 1986; 61: 1233–5.
8. Elders MJ, Garland JT, Daughaday WA, Fisher DA, Whitney JE, Hughes ER. Laron's dwarfism: studies on the nature of the defect. J Pediatr 1973; 83: 253–63.
9. Laron Z, Kowadlo-Silbergeld A, Eshet R, Pertzelan A. Growth hormone resistance. Ann Clin Res 1980; 12: 269–77.
10. Alcaniz J, Salto L, Barcelo B. GH secretion in two siblings with Laron's dwarfism: the effects of glucose, arginine, somatostatin, and bromocriptine. J Clin Endocrinol Metab 1978; 47: 453–6.
11. Golde DW, Bersch N, Kaplan SA, Rimoin DL, Li CH. Peripheral unresponsiveness to human growth hormone in Laron dwarfism. N Engl J Med 1980; 303: 1156–9.
12. Godowski PJ, Leung DW, Meacham LR, et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989; 86: 8083–7.
13. Van den Brande JL, Du Caju MVL, Visser HKA, Schopman W, Hackeng WHL, Degenhart HJ. Primary somatomedin deficiency: case report. Arch Dis Child 1974; 49: 297–304.
14. Amselem S, Duquesnoy P, Attree O. et al. Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 1989; 321: 989–95.
15. Spadoni GL, Cianfarani S, Baldini A, et al. Laron dwarfism: cellular unresponsiveness to GH demonstrated on cultured lymphocytes by a cytochemical method. Horm Metab Res 1988; 20: 450–2.
16. Roth-Schechter BF. Bonardi JM, Juif JG. Inhibitor action of serum from a Laron dwarf on normal cellular function. Experientia 1983; 39: 606–8.
17. Eshet R, Laron Z, Pertzelan A, Amon R, Dintzman M. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci 1984; 20: 8–11.
18. Daughaday WH, Trivedi B. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci U S A 1987; 84: 4636–40.
19. Baumann G, Shaw MA, Winter RJ. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism. J Clin Endocrinol Metab 1987; 65: 814–6.
20. Laron Z, Klinger B, Erster B, Silbergeld A. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. Acta Endocrinol (Copenh) 1989; 121: 603–8.
21. Meacham LR, Murphy TC, Klinger C, Erster B, Laron Z, Parks JS. Heterogeneity of molecular defects causing Laron type dwarfism. In: The Endocrine Society-72nd annual meeting, program and abstracts, June 20–23, 1990, Atlanta, Ga. Bethesda, Md.: Endocrine Society, 1990:373. abstract.
22. Bass S, Wells J. Growth hormone-receptor gene in Laron dwarfism. N Engl J Med 1990; 322: 854–5.
23. National Center for Health Statistics, Hamil PVV. NCHS growth curves for children birth-18 years: United States. Vital and health statistics. Series 11. No. 165. Washington, D.C.: Government Printing Office, 1977. (DHEW publication no. (PHS) 78–1650.)
24. Wilkins L. The diagnosis and treatment of endocrine disorders in childhood and adolescence. 3rd ed. Springfield, Ill.: Charles C Thomas, 1965:33.
25. Jones KL. Smith's recognizable patterns of human malformation. 4th ed. Philadelphia: W.B. Saunders, 1988:695–8.
26. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, Calif.: Stanford University Press, 1959.
27. Celniker achéal, Chen AB, Wert RM Jr, Sherman BM. Variability in the quantitation of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab 1989; 68: 469–76.
28. Baumann G, Amburn K, Shaw MA. The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man. Endocrinology 1988; 122: 976–84.
29. Powell DR, Rosenfeld RG, Baker BK, Liu F, Hintz RL. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor (IGF-I) and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab 1986; 63: 1186–92.
30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5.
31. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76: 4350–.
32. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138–43.
33. Rosenfeld RG, Wilson DM, Lee PD, Hintz RL. Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr 1986; 109: 428–33.
34. Van den Brande JL, Van Wyk JJ, French FS, Strickland AL, Radcliffe WB. Advancement of skeletal age of hypopituitary children treated with thyroid hormone plus cortisone. J Pediatr 1973; 82: 22–7.
35. Rosenbloom AL, Netzloff ML, Garnica AD, Weber FT. Replacement therapy with human growth hormone (hGH): efficacy of low dosage and need for routine thyroid replacement. Acta Paediatr Belg 1979; 32: 173–9.
36. Rivarola MA, Phillips JA III, Migeon CJ, Heinrich JJ, Hjelle BJ. Phenotypic heterogeneity in familial isolated growth hormone deficiency type I-A. J Clin Endocrinol Metab 1984; 59: 34–40.
37. Pintor C, Loche S, Celia SG, Müller EE, Baumann G. A child with phenotypic Laron dwarfism and normal somatomedin levels. N Engl J Med 1989; 320: 376–9.
38. Laron Z. Laron-type dwarfism (hereditary somatomedin deficiency): a review. Ergeb Inn Med Kinderheilkd 1984; 51: 117–50.
39. Murphy LJ, Friesen HG. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology 1988; 122: 325–32.